What is lumbrokinase's main role?

Lumbrokinase is an antithrombotic drug, which is mainly used clinically for thrombotic diseases, especially patients with increased fibrinogen and increased platelet aggregation rate; for ischemic cardiovascular and cerebrovascular diseases, it can improve symptoms and prevent disease development.

Mainly treat diseases of lumbrokinase

1. Coronary heart disease

Urokinase mainly activates plasminogen in plasma to convert it into plasmin with thrombolytic activity, thereby degrading fibrinogen and fibrin clot, and melting thrombus. The lumbrokinase can also directly melt fibrin.

2. Cerebral infarction

The use of lumbrokinase to treat cerebral infarction has a significant effect on the recovery of patients with paralyzed limbs, can effectively improve the clinical symptoms and signs of patients with cerebral infarction, reduce the patient's sickness rate, and have mild sequelae symptoms, and the apparent efficiency and effective rate are significantly better than that of Abdomen Shuan Enzyme and Xueshuan Xinmaining.

3. Diabetes

Plasma TXB2 levels of diabetic patients decreased significantly after oral administration of lumbrokinase for 2 weeks, and there was no significant difference from the control group, suggesting that lumbrokinase has a significant inhibitory effect on platelet adhesion and aggregation. Plasma GMP140 levels also decreased significantly after treatment, indicating that lumbrokinase can inhibit platelet activation in diabetic patients to a certain extent.

4. Nephrotic syndrome

Lumbrokinase has anticoagulant and thrombolytic effects to improve glomerular microcirculation, achieving the purpose of reducing urine protein and improving renal function.

5. Cor pulmonale

The clinical study of lumbrokinase on pulmonary heart disease confirmed that the patient's blood rheology indicators have changed significantly, the clinical symptoms have improved, and the total effective rate of treatment is 88.4%. It is a safe and effective antithrombolytic drug for the treatment of pulmonary heart disease.